Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

Author:

Solanes AleixORCID,Mezquida Gisela,Janssen Joost,Amoretti SilviaORCID,Lobo AntonioORCID,González-Pinto Ana,Arango CelsoORCID,Vieta Eduard,Castro-Fornieles JosefinaORCID,Bergé Daniel,Albacete Auria,Giné EloiORCID,Parellada Mara,Bernardo MiguelORCID,Bioque Miquel,Morén Constanza,Pina-Camacho Laura,Díaz-Caneja Covadonga M.,Zorrilla Iñaki,Corres Edurne Garcia,De-la-Camara Concepción,Barcones Fe,Escarti María José,Aguilar Eduardo Jesus,Legido Teresa,Martin Marta,Verdolini Norma,Martinez-Aran Anabel,Baeza Immaculada,de la Serna Elena,Contreras Fernando,Bobes Julio,García-Portilla María Paz,Sanchez-Pastor Luis,Rodriguez-Jimenez Roberto,Usall Judith,Butjosa Anna,Salgado-Pineda Pilar,Salvador Raymond,Pomarol-Clotet Edith,Radua Joaquim,

Abstract

AbstractDetecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18–24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.

Publisher

Springer Science and Business Media LLC

Reference45 articles.

1. DeLisi, L. E. et al. Cerebral ventricular enlargement as a possible genetic marker for schizophrenia. Psychopharmacol. Bull. 21, 365–367 (1985).

2. Radua, J. & Carvalho, A. F. Route map for machine learning in psychiatry: absence of bias, reproducibility, and utility. Eur. Neuropsychopharmacol. 50, 115–117 (2021).

3. Rosen, M. et al. Towards clinical application of prediction models for transition to psychosis: a systematic review and external validation study in the PRONIA sample. Neurosci. Biobehav. Rev. 125, 478–492 (2021).

4. Smieskova, R. et al. Neuroimaging predictors of transition to psychosis-a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 34, 1207–1222 (2010).

5. Schmidt, A. et al. Improving prognostic accuracy in subjects at clinical high risk for psychosis: systematic review of predictive models and meta-analytical sequential testing simulation. Schizophrenia Bull. 43, 375–388 (2017).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3